HK:3933 Stock Latest News
Company AnnouncementsUnited Laboratories Wins Novo Milestone for UBT251 Diabetes and Obesity Drug1M ago
Company AnnouncementsUnited Laboratories Wins Acceptance for First-in-China IDegLira Biosimilar Filing1M ago
Company AnnouncementsUnited Laboratories Advances UBT251 Into Phase III Diabetes Trials in China1M ago
Company AnnouncementsUnited Laboratories Begins Phase III Dosing of Obesity Drug UBT251 in China1M ago- Company AnnouncementsUnited Laboratories Corrects 2026 Interim Capital Commitments Disclosure1M ago
Company AnnouncementsUnited Laboratories’ Interim Profit Plunges, Interim Dividend Scrapped2M ago
Company AnnouncementsUnited Laboratories Schedules Board Meeting to Approve 2026 Interim Results2M ago
- Company AnnouncementsUnited Laboratories Wins FDA IND Nod for Novel Obesity and Diabetes Drug2M ago
Company AnnouncementsUnited Laboratories Secures Novo Nordisk Milestone for Obesity Drug UBT2513M ago
Company AnnouncementsUnited Laboratories Wins Approval for New Multi-Dose Eye Drops in China3M ago
Company AnnouncementsUnited Laboratories Wins China Approval for New Tadalafil Men’s Health Drug4M ago
Company AnnouncementsUnited Laboratories Executive Director Fang Yu Ping to Retire After 30 Years of Service4M ago
- Company AnnouncementsUnited Laboratories Confirms 2025 Final Dividend and Payment Timetable4M ago
- Company AnnouncementsUnited Laboratories Wins Strong Shareholder Backing at 2026 AGM, Approves Dividend and Capital Mandates4M ago
Company AnnouncementsUnited Laboratories Wins China Approval to Start Trials of New Autoimmune Drug TUL3214M ago
Company AnnouncementsUnited Laboratories Plans HK$200 Million Share Buy-Back to Boost Shareholder Value4M ago
Company AnnouncementsUnited Laboratories Wins China, U.S. Approvals to Advance New Anti-Infective Drug TUL1085M agoCompany AnnouncementsUnited Laboratories Executive Director Zhu Su Yan Resigns After Three Decades of Service5M ago